An interventional study of Pantomiming and Easy onset in Stammering, sponsored by Riphah International University. Status unknown at 1 site in Pakistan. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2021-03-24.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
This research will give in-depth understanding of pantomiming and easy onset method as an intervention of stuttering and especially blocking. And by comparing both methods, It will also determine that which method is more effective. This research will also improve the overall awareness regarding stuttering
Research participants will be divided into two groups through randomization, Group A \& Group B. Base line assessment will be conducted. Intervention will be provided (thrice a week on alternative days).post assessment will be taken and data will be analyzed through SPSS.
74 studies on the registry are indexed under Stuttering; 23 are open to participants now.
This study's planned enrollment of 20 is below the median of 44 across 57 interventional studies indexed under Stuttering.
Browse Stuttering studies →Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
In experimental group pantomiming treatment will be administered
Other: Pantomiming
In active comparator group easy onset method will be administered
Other: Easy onset
Pantomiming with fluency shaping techniques
Easy onset method with breathing exercises
The real time analysis
Changes from base line "The Real time analysis will use. It will use to assessed the changes in frequency ,duration types and severity of disfluencies in spontaneous speech.The total number of dysfluencies will be divided by the total number of syllables then multiply answer by 100 .Results between 2% showed normal range,8-15% will consider Moderate level, 12% will consider as severe level
Time frame: 12 weeks
Plan to share: No
This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riphah International University →